Funding shortfall threatens progress of new Ebola vaccine candidates

A rapidly expanding Ebola outbreak in Africa has spurred multiple groups to accelerate vaccine development.

The effort is being coordinated by a key global health organization, but the group is facing a severe funding gap that could slow or halt projects.

Researchers warn that without additional resources, promising vaccine candidates may not reach clinical testing in time to curb the spread.

Securing new financing from governments, donors, or private investors will be critical to sustain the momentum.